BamSEC and AlphaSense Join Forces
Learn More

Organovo Holdings Inc.

NASDAQ: ONVO    
Share price (12/20/24): $0.36    
Market cap (12/20/24): $5.532 million

Material Contracts Filter

EX-10.1
from 8-K 26 pages Organovo Holdings, Inc. Amended and Restated 2022 Equity Incentive Plan (As Amended and Restated on November 20, 2024) 1. Purpose of the Plan. the Purpose of This Plan Is To: • to Attract and Retain the Best Available Personnel for Positions of Substantial Responsibility, • to Provide Additional Incentive to Employees, Directors and Consultants, and • to Promote the Success of the Company’s Business. the Plan Permits the Grant of Incentive Stock Options, Nonstatutory Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Units and Performance Shares. 2. Definitions. the Following Definitions Are Used in This Plan: (A) “Administrator” Means the Board or Any of Its Committees as Will Be Administering the Plan, in Accordance With Section 4 of the Plan
12/34/56
EX-10.2
from 8-K 22 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 21 pages Placement Agency Agreement
12/34/56
EX-10.42
from S-1/A 20 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 15 pages The Plan Includes Two Components: A 423 Component and a Non-423 Component. the Company Intends (But Makes No Undertaking or Representation to Maintain) the 423 Component to Qualify as an Employee Stock Purchase Plan. the Provisions of the 423 Component, Accordingly, Will Be Construed in a Manner That Is Consistent With the Requirements of Section 423 of the Code. Except as Otherwise Provided in the Plan or Determined by the Board, the Non-423 Component Will Operate and Be Administered in the Same Manner as the 423 Component. (C) the Company, by Means of the Plan, Seeks to Retain the Services of Such Employees, to Secure and Retain the Services of New Employees and to Provide Incentives for Such Persons to Exert Maximum Efforts for the Success of the Company and Its Related Corporations. 2. Administration. (A) the Board or the Committee Will Administer the Plan. References Herein to the Board Shall Be Deemed to Refer to the Committee Except Where Context Dictates Otherwise. (B) the Board Will Have the Power, Subject To, and Within the Limitations Of, the Express Provisions of the Plan: (I) to Determine How and When Purchase Rights Will Be Granted and the Provisions of Each Offering (Which Need Not Be Identical)
12/34/56
EX-10.1
from 8-K/A 7 pages Separation Agreement and General Release
12/34/56
EX-10.1
from 8-K 6 pages Separation Agreement and General Release
12/34/56
EX-10.38
from 10-K 88 pages Asset Purchase Agreement Acquisition of Certain Assets of Metacrine, Inc. by Organovo, Inc. Dated as of March 10, 2023
12/34/56
EX-10.1
from 8-K 25 pages Organovo Holdings, Inc. 2022 Equity Incentive Plan
12/34/56
EX-10.34
from 10-K 23 pages Settlement and Patent License Agreement
12/34/56
EX-10.1
from 8-K 88 pages First Amendment to Amended and Restated Lease Between San Diego Inspire 2, LLC, as Landlord, and Organovo, Inc., as Tenant
12/34/56
EX-10.3
from 8-K 3 pages Amendment No. 5 to Consulting Agreement
12/34/56
EX-10.1
from 8-K 16 pages Organovo Holdings, Inc. Amended and Restated 2012 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 12 pages Organovo Holdings, Inc. 2021 Inducement Equity Incentive Plan
12/34/56
EX-10.1
from 8-K 16 pages Organovo Holdings, Inc. Amended and Restated 2012 Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 4 pages Organovo, Inc. 440 Stevens Avenue, Suite 200 Solana Beach, Ca 92075 December 28, 2020
12/34/56
EX-10.1
from 8-K 17 pages Intercompany Agreement
12/34/56
EX-10.2
from 8-K 81 pages Lease Sova Central Science District San Diego Inspire 2, LLC a Delaware Limited Liability Company as Landlord, and Organovo Holdings, Inc. a Delaware Corporation as Tenant
12/34/56
EX-10.1
from 8-K 66 pages Lease Sova Science District San Diego Inspire 1, LLC, a Delaware Limited Liability Company, as Landlord, and Organovo Holdings, Inc., a Delaware Corporation, as Tenant
12/34/56
EX-10.4
from 10-Q 9 pages Via E-Mail: Jbush@organovo.com
12/34/56